Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$2 Mln
P/E Ratio
--
P/B Ratio
0.08
Industry P/E
--
Debt to Equity
0.14
ROE
-0.5 %
ROCE
-12.92 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$21.53 Mln
EBITDA
$35.40 Mln
Net Profit
$19.13 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Universe Pharmaceuticals Inc (UPC)
| 618.03 | -10.43 | 748.02 | -86.61 | -65.56 | -- | -- |
BSE Sensex*
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2023
|
2022
|
|
---|---|---|
Universe Pharmaceuticals Inc (UPC)
| -76.90 | -11.31 |
S&P Small-Cap 600
| 13.89 | -17.42 |
BSE Sensex
| 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
0.96 | 7.14 | 3.16 | -13.93 | |
0.07 | 0.99 | 0.38 | 1 | |
9.50 | 487.51 | -- | -29.04 |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic... health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. Address: 265, Jingjiu Avenue, Ji'An, China, 343100 Read more
CEO & Chairman
Mr. Gang Lai
CEO & Chairman
Mr. Gang Lai
Headquarters
Ji'An
Website
The total asset value of Universe Pharmaceuticals Inc (UPC) stood at $ 53 Mln as on 30-Sep-23
The share price of Universe Pharmaceuticals Inc (UPC) is $4.38 (NASDAQ) as of 29-Apr-2025 16:22 EDT. Universe Pharmaceuticals Inc (UPC) has given a return of -65.56% in the last 3 years.
Universe Pharmaceuticals Inc (UPC) has a market capitalisation of $ 2 Mln as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Universe Pharmaceuticals Inc (UPC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Universe Pharmaceuticals Inc (UPC) and enter the required number of quantities and click on buy to purchase the shares of Universe Pharmaceuticals Inc (UPC).
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. Address: 265, Jingjiu Avenue, Ji'An, China, 343100
The CEO & director of Mr. Gang Lai. is Universe Pharmaceuticals Inc (UPC), and CFO & Sr. VP is Mr. Gang Lai.
There is no promoter pledging in Universe Pharmaceuticals Inc (UPC).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
49
|
|
1
|
|
0
|
|
49
|
Universe Pharmaceuticals Inc (UPC) | Ratios |
---|---|
Return on equity(%)
|
-14.34
|
Operating margin(%)
|
-11.53
|
Net Margin(%)
|
-19.08
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Universe Pharmaceuticals Inc (UPC) was No Profit.